GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elicera Therapeutics AB (OSTO:ELIC) » Definitions » Other Long-Term Liabilities

Elicera Therapeutics AB (OSTO:ELIC) Other Long-Term Liabilities : kr0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Elicera Therapeutics AB Other Long-Term Liabilities?

Elicera Therapeutics AB's other long-term liabilities for the quarter that ended in Jun. 2024 was kr0.00 Mil.

Elicera Therapeutics AB's quarterly other long-term liabilities declined from Dec. 2023 (kr5.01 Mil) to Mar. 2024 (kr0.00 Mil) but then stayed the same from Mar. 2024 (kr0.00 Mil) to Jun. 2024 (kr0.00 Mil).

Elicera Therapeutics AB's annual other long-term liabilities stayed the same from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr0.00 Mil) but then increased from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr5.01 Mil).

Elicera Therapeutics AB Other Long-Term Liabilities Historical Data

The historical data trend for Elicera Therapeutics AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elicera Therapeutics AB Other Long-Term Liabilities Chart

Elicera Therapeutics AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
- - - - -

Elicera Therapeutics AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Elicera Therapeutics AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Elicera Therapeutics AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Elicera Therapeutics AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Elicera Therapeutics AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elicera Therapeutics AB (OSTO:ELIC) » Definitions » Other Long-Term Liabilities
Comparable Companies
OSTO:ISOFOL OSTO:SPRINT OSTO:ALZ OSTO:BIOVIC B OSTO:NXTCL XSAT:CESSA OSTO:ACE OSTO:ZICC OSTO:SIMRIS B OSTO:LIPUM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Massans gata 10, World Trade Center Goteborg, 7th Floor, Goteborg, SWE, SE-412 51
Website
https://www.elicera.com
Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments. The company's product portfolio consists of four drug candidates, two in the field of oncolytic viruses (ELC-100 and ELC-201) and two in the field of CAR T-cell treatments (ELC-301 and ELC-401), in addition to a universal CAR T-cell technology platform, iTANK (ELC-001), compatible with any CAR T-cell therapy for a multi-targeted attack on solid tumors.

Elicera Therapeutics AB Headlines

No Headlines